Manufacturing Chemist Stand Side with Stevanato Group

Published: 11-Feb-2025
Sustainability Drug Delivery

We discover what exhibitors at Pharmapack 2025 are showcasing LIVE!

Sponsored by Stevanato Group

In this interview, Manufacturing Chemist Stand Side speaks with Stevanato Group at Pharmapack 2025.

For more interviews with leading companies from across the manufacturing pharmaceuticals industry, visit our YouTube channel and hit subscribe.

 

 

Manufacturing Chemist Stand Side...

"Manufacturing Chemist Stand Side" is a series of exclusive video interviews with leading companies in the pharmaceutical industry, conducted during key market events by our award-winning B2B team.

For more information on how you can be part of "Manufacturing Chemist Stand Side" contact Don Phares on +44 207 193 3219 or via email: don@hpcimedia.com.

  • Companies:
  • Stevanato Group
See more

You may also like

Manufacturing

SCHOTT, Gerresheimer and Stevanato Group form the 'Alliance for RTU'

Read more
The scheme will promote the adoption of ready-to-use (RTU) vials and cartridges for CDMOs in the injectable scene

Trending Articles

  1. GSK and the WWF team up to bolster pharmaceutical sustainability The five year partnership between GSK and the conservation organisation will aim to restore freshwater ecosystems near to its manufacturing sites in India and Pakistan
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Navigating ESG challenges in pharma and logistics: the road to sustainability Jake Brown, Commercial Lead at LogiPharma, discusses the upcoming 25th edition of the conference and how some of its key sponsors are navigating ESG challenges
  3. Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    DCAT preview: the future of pharma manufacturing Ahead of the upcoming trade show, Dr Kevin Robinson caught up with pharmaceutical industry experts to discuss how they’re innovating for resilience and sustainability in 2025 and beyond
  5. The colouration of tablets and capsules Paul Smith from Sensient Pharmaceutical Technologies discusses the use of colour in solid oral dosage forms

Upcoming event

Interphex

1–3 April 2025 | Conference and Exhibition | New York, US See all

You may also like

Manufacturing

SCHOTT, Gerresheimer and Stevanato Group form the 'Alliance for RTU'

The scheme will promote the adoption of ready-to-use (RTU) vials and cartridges for CDMOs in the injectable scene
Distribution

DWK enters into distribution agreement with drug containment specialist Stevanato

The collaboration will leverage DWK Life Sciences experience in supplying a global network of laboratories and biopharma customers to broaden the distribution of RTU products
Drug Delivery

Expanding capacity through collaboration

Michael Earl, Director of Pharmaceutical Services at Owen Mumford, and Steven Kaufman, Vice President for Drug Delivery Systems, Stevanato Group, talk to Dr Kevin Robinson about their new partnership
Distribution

Manufacturing Chemist LIVE 2022 in review (part II)

Taking a front row seat during the two-day pharmaceutical conference in Birmingham, UK, Dr Kevin Robinson reports on what’s new, emerging and exciting in the world of drug delivery and beyond
Manufacturing

Steriline, Araymond and Stevanato Group together for a combined solution for laboratory batches

An all-in-one closure system for a superior quality in drugs primary packaging to enhance patient safety
Drug Delivery

Stevanato and Bexson Biomedical to develop a customised wearable ketamine delivery device

Patients suffering from chronic and acute pain disorders will benefit from a convenient, discreet and easy-to-use device delivering a novel alternative to opioid-based pain management
Packaging

Key considerations for success when selecting primary container packaging in drug development

The selection of appropriate primary container packaging for an injectable drug product is one of the most fundamental considerations in the drug development process. The wrong choice can cost significant time and resources later in the process and cause regulatory issues
Subscribe now